Frontlight ResearchEarly access
TerminatedPhase 4
Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure
Key facts
- Who runs it
- Radha Gopalan
- Where
- Phoenix, United StatesSee the site
- Trial code
- Status
- Terminated
- Phase
- Phase 4
- People taking part
- 6 people enrolled
- Started
- 24 Jan 2024
- Ended
- 18 Nov 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- IV Iron Infusion Group
- Record updated
- 29 July 2026
- Why it stopped
- Difficulty with accrual.
Who can take part
- Age
- 18 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Age 18-90 years
- New York Heart Association Class II-III heart failure
- Left ventricular dysfunction with left ventricular ejection fraction ≤ 40%
- Ferritin < 100 ng/mL or 100-300 ng/mL with transferrin saturation (TSAT) < 20%
- Patients deemed by an attending physician to require intravenous iron therapy
- The patient is willing and able to comply with the protocol and has provided written informed consent
Who cannot take part
- Iron overload disorders or allergy, concomitant nutritional deficiencies- B12 and folate
- Recent Acute Coronary Syndrome
- Currently presenting in heart failure exacerbation
- Chronic liver disease
- Active bleeding
- Physical barriers to exercise capacity
- Declined participation
- NYHA class IV
- Pregnancy
- Life expectancy ≤ 12 months
Where in United States
- Banner - University Medical Center, Phoenix campusPhoenix, United States
About the trial
What the trial wants to find out
Patients with heart failure with reduced ejection fraction and iron deficiency will be randomized to either receive iron infusion or be in the control group. The study is looking at how iron replacement affects exercise capacity as measured by peak oxygen uptake.
The 2 groups in the trial
- IV Iron Infusion GroupTreatment being tested
Subjects will receive iron infusion 1 week after enrollment. Dosage of iron will be at discretion of physicians
- Control GroupNo study treatment, for comparison
Subjects will not receive iron replacement infusion.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure With Reduced Ejection Fraction and Iron Deficiency
- Record updated
- 29 July 2026